Mackay Shields LLC’s Viemed Healthcare VMD Stock Holding History

Mackay Shields LLC’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19,933	Closed	-$202K	–	1319
2021 Q1	$202K	Sell	19,933 -27,567	-58%	-$259K	﹤0.01%	1414
2020 Q4	$368K	Buy	47,500 +10,000	+27%	+$88K	﹤0.01%	1315
2020 Q3	$324K	Sell	37,500 -174,800	-82%	-$1.76M	﹤0.01%	1265
2020 Q2	$2.04M	Buy	+212,300	New	+$1.65M	0.02%	748

Other funds holding VMD

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Mackay Shields LLC's VMD Position: Q2 2021 in Review

Mackay Shields LLC sold out of Viemed Healthcare (VMD) in Q2 2021, closing a stake of 19,933 shares — an estimated $202K sold.

Mackay Shields LLC first reported a position in VMD in Q2 2020 and held it in 4 quarters. The position peaked at $2.04M in Q2 2020. 77 funds tracked by Wall St. Rank hold VMD as of Q2 2021.

Mackay Shields LLC reported no remaining Viemed Healthcare position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 19,933 Viemed Healthcare shares in Q2 2021, an estimated $202K.
Mackay Shields LLC first reported a position in Viemed Healthcare in Q2 2020 and held it in 4 quarters.
Mackay Shields LLC's Viemed Healthcare position peaked at $2.04M in Q2 2020.
77 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.